Evaluation of WHO normative function at country level: executive summary
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
World Health Organization
Abstract
Description
7 p.
This executive summary presents the findings, conclusions and recommendations of the evaluation of WHO’s normative function at country level, conducted as part of the WHO Evaluation Office biennial workplan for 2022–2023. The evaluation assesses how WHO normative products are identified, developed, disseminated and used at country level, and examines their contribution to health-related outcomes. Using a theory-based approach, the evaluation reviewed six selected normative products and carried out country case studies in Ethiopia, Jordan, Maldives, Pakistan, the Philippines, Rwanda and Uganda. It analysed the involvement of WHO headquarters, regional offices and country offices in normative processes, the use of normative guidance by national stakeholders, and factors influencing implementation and impact. The report finds that WHO normative products are highly valued for their technical credibility and evidence base and are widely used to support policy development, health system strengthening and service delivery. At the same time, it identifies limitations related to country participation in product development, implementation support, monitoring and resource allocation. The evaluation highlights the need for stronger feedback mechanisms, better integration of normative work into country planning processes, improved monitoring of outcomes and greater attention to gender equality, health equity and human rights considerations in WHO normative work.
This executive summary presents the findings, conclusions and recommendations of the evaluation of WHO’s normative function at country level, conducted as part of the WHO Evaluation Office biennial workplan for 2022–2023. The evaluation assesses how WHO normative products are identified, developed, disseminated and used at country level, and examines their contribution to health-related outcomes. Using a theory-based approach, the evaluation reviewed six selected normative products and carried out country case studies in Ethiopia, Jordan, Maldives, Pakistan, the Philippines, Rwanda and Uganda. It analysed the involvement of WHO headquarters, regional offices and country offices in normative processes, the use of normative guidance by national stakeholders, and factors influencing implementation and impact. The report finds that WHO normative products are highly valued for their technical credibility and evidence base and are widely used to support policy development, health system strengthening and service delivery. At the same time, it identifies limitations related to country participation in product development, implementation support, monitoring and resource allocation. The evaluation highlights the need for stronger feedback mechanisms, better integration of normative work into country planning processes, improved monitoring of outcomes and greater attention to gender equality, health equity and human rights considerations in WHO normative work.